共 21 条
[1]
InvitroactivityofBAY 128039,anew8 methoxyquinoloneagainstmycobacteria[posterno.F -144]. CrossWM,VadneyFS,LadutkoL ,etal. 37thInterscienceConferenceonAntimi crobialAgentsandChemotherapy(ICAAC) . 1997
[2]
Susceptibilitiesofhumanmycoplas mastoBAY 128039. KennyGE,CartwrightFD. 37thInterscienceConferenceonAntimi crobialAgentsandChemotherapy(ICAAC) . 1997
[3]
Antipneumococcalactiv ityofBAY 128039comparedtootherdrugsbytime kill[posterno.F 133]. VisalliMA,JacobsMR,AppelbaumPC. 37thInterscienceConferenceonAntimicrobialA gentsandChemotherapy(ICAAC) . 1997
[4]
AntimicrobialresistanceofStreptococcuspneumoniacisolatedfromout patientsintheUnitedStatesduringthewintermonthsof1994to1995:resultsofa30 centernationalsurveillancestudy. DoemGV,BrueggemannA,HolleyHP ,etal. Antimicrobial Agents and Chemotherapy . 1996
[5]
Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona. Pallares R,Linares J,Vadillo M,et al. Spain N Engl J Med . 1995
[6]
Sequential surveillance of antimicrobial resistance in the United States: Streptococcus pneumoniae ( SP ), Haemophilus influenzae ( HI ), and Moraxella catarrhalis (MC) (1997-98 vs 1996-97). Thornsberry C,Hickey ML,Khan J,et al. 6th International Symposium on New Quinolones[abstract 47] . 1998
[7]
Respiratory tract infections-getting where it matters. Wise R. 8th international congress on infectious diseases[abstract] . 1998
[8]
Epidemiology of quinolone resistance:Europe and North and South America. Goldstein FW,Acar JF. Drugs . 1995
[9]
Invitroactivi tyofBAY 128039,anewfluoroquinolone.againstmycoplasmas. MacGowanCM,RenaudinH,BoudjadjaA ,etal. Antimicrobial Agents and Chemotherapy . 1998
[10]
ActivityofmoxifloxacinagainstMy cobacteriumspp[abstractno.50.021]. GillespieSH,BillingtonO. 8thIntermationalCon gresonInfectiousDiseases(ICID) . 1998